We have described the variability of effects of LDH-A KD on the three glioma cell lines, including differences in their glycolytic and oxidative metabolic profiles, and subcutaneous tumor-growth characteristics in immunocompetent vs. incompetent host animals (accompanying manuscript [17]). The gene discussed is LDHA; the disease is neoplasm.